Depletion lymphocytapheresis therapy using the continuous-flow separator was used in twenty-two cases of chronic lymphocytic leukemia. Applying the Montserrat scoring system, a prediction can be made, to a good approximation, whether the patient will be a “responder” or a “non-responder” to leukapheresis.
Criteria have been formulated for decisions on when depletion lymphocytapheresis is absolutely or only relatively indicated, on the basis of total scores from 2 through 6 using the Montserrat criterion.
CooperI.A., DingJ.C., AdamsP.B., QuinnM.A., BrettellM.: Intensive leukapheresis in the management of cytopenias in patients with chronic leukemia and lymphocytic lymphoma.Am. J. Hematol, 6, 387, 1979.
FortunyL.E., HadlockD.C., KennedyB.J., TheologidesA., McCulloughJ.: The rate of continuous flow centrifuge leukapheresis in the manegement of chronic lymphocytic leukemia.Brit. J. Haemat.32, 609, 1976.
6.
GaltonD.A.: The chronic leukemias in recent advances in haematology:Churchill Livingstone1977.
7.
GoldfingerD., CapostagnoV., LoweC., SacksH.J., GattiR.A.: Use of long-term leukapheresis in the treatment of chronic lymphocytic leukemia.Transfusion, 20, 450, 1980.
8.
HockerP., PittermanE., GobetsM., StacherA.: Treatment of patients with chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL) by Leucapheresis with a continuous flow blood cell separator. In Leukocytes: separation, collection and transfusion. Ed. GoldmanJ.M., and LowenthamJ.M., Academic Press510, 1975.
9.
HoelzerD., KurzleE., DietrichM., and Meyer-HammeJ., FliednerM: The effect of continuous cell removal.Cell kinetics in acute leukemia. Scand. J. Haemat.12, 311, 1974.
10.
MontserratE., RozmanC.: Sub-classification of stage II chronic lymphocytic leukemia with prognostic and therapeutic implications.Lancet2, 854, 1979.
11.
PolianskaiaA.M., KhoroshkoN.D., BaidurinS.A., KalininN.N., KasatkinaV.V.: Mechanisms of the therapeutic action of leukapheresis in leukemias.Probl. Gematol. Pereliv. Krovi26, 6, 1981.